HSBC Knock-Out INCY/ DE000HS2DCZ3 /
| 2024-11-06 6:00:33 PM | Chg.+0.470 | Bid6:18:44 PM | Ask6:18:44 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 3.680EUR | +14.64% | 3.640 Bid Size: 30,000 |
3.650 Ask Size: 30,000 |
Incyte Corporation | 42.3882 USD | 2078-12-31 | Call |
GlobeNewswire
08-16
China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...
GlobeNewswire
08-06
MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire
08-01
Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire
07-30
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...
GlobeNewswire
06-25
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...
GlobeNewswire
05-09
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire
05-08
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
04-02
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire
04-01
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire
02-28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
01-09
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
2023-12-09
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire
2023-11-16
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire
2023-11-02
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
